These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 15658869)
1. Further naphthylcombretastatins. An investigation on the role of the naphthalene moiety. Maya AB; Pérez-Melero C; Mateo C; Alonso D; Fernández JL; Gajate C; Mollinedo F; Peláez R; Caballero E; Medarde M J Med Chem; 2005 Jan; 48(2):556-68. PubMed ID: 15658869 [TBL] [Abstract][Full Text] [Related]
2. A new family of quinoline and quinoxaline analogues of combretastatins. Pérez-Melero C; Maya AB; del Rey B; Peláez R; Caballero E; Medarde M Bioorg Med Chem Lett; 2004 Jul; 14(14):3771-4. PubMed ID: 15203159 [TBL] [Abstract][Full Text] [Related]
3. Naphthylphenstatins as tubulin ligands: synthesis and biological evaluation. Alvarez C; Alvarez R; Corchete P; Pérez-Melero C; Peláez R; Medarde M Bioorg Med Chem; 2008 Oct; 16(19):8999-9008. PubMed ID: 18790642 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of 4-arylcoumarin analogues of combretastatins. Bailly C; Bal C; Barbier P; Combes S; Finet JP; Hildebrand MP; Peyrot V; Wattez N J Med Chem; 2003 Dec; 46(25):5437-44. PubMed ID: 14640552 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological activity of naphthalene analogues of phenstatins: naphthylphenstatins. Alvarez C; Alvarez R; Corchete P; Pérez-Melero C; Peláez R; Medarde M Bioorg Med Chem Lett; 2007 Jun; 17(12):3417-20. PubMed ID: 17434303 [TBL] [Abstract][Full Text] [Related]
6. 1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin. Odlo K; Hentzen J; dit Chabert JF; Ducki S; Gani OA; Sylte I; Skrede M; Flørenes VA; Hansen TV Bioorg Med Chem; 2008 May; 16(9):4829-38. PubMed ID: 18396050 [TBL] [Abstract][Full Text] [Related]
7. Lead identification of conformationally restricted β-lactam type combretastatin analogues: synthesis, antiproliferative activity and tubulin targeting effects. Carr M; Greene LM; Knox AJ; Lloyd DG; Zisterer DM; Meegan MJ Eur J Med Chem; 2010 Dec; 45(12):5752-66. PubMed ID: 20933304 [TBL] [Abstract][Full Text] [Related]
8. 2-(6-aryl-3(Z)-hexen-1,5-diynyl)anilines as a new class of potent antitubulin agents. Lo YH; Lin CC; Lin CF; Lin YT; Duh TH; Hong YR; Yang SH; Lin SR; Yang SC; Chang LS; Wu MJ J Med Chem; 2008 May; 51(9):2682-8. PubMed ID: 18386884 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents. Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783 [TBL] [Abstract][Full Text] [Related]
10. Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-combretastatin A-41. Pettit GR; Rhodes MR; Herald DL; Hamel E; Schmidt JM; Pettit RK J Med Chem; 2005 Jun; 48(12):4087-99. PubMed ID: 15943482 [TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and cytotoxic activities of naphthyl analogues of combretastatin A-4. Maya AB; del Rey B; Lamamie de Clairac RP; Caballero E; Barasoain I; Andreu JM; Medarde M Bioorg Med Chem Lett; 2000 Nov; 10(22):2549-51. PubMed ID: 11086727 [TBL] [Abstract][Full Text] [Related]
12. Novel combretastatin analogues effective against murine solid tumors: design and structure-activity relationships. Ohsumi K; Nakagawa R; Fukuda Y; Hatanaka T; Morinaga Y; Nihei Y; Ohishi K; Suga Y; Akiyama Y; Tsuji T J Med Chem; 1998 Jul; 41(16):3022-32. PubMed ID: 9685242 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationships of 3-aminobenzophenones as antimitotic agents. Liou JP; Chang JY; Chang CW; Chang CY; Mahindroo N; Kuo FM; Hsieh HP J Med Chem; 2004 May; 47(11):2897-905. PubMed ID: 15139768 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, biological evaluation and molecular modeling of 1,3,4-oxadiazoline analogs of combretastatin-A4 as novel antitubulin agents. Hu Y; Lu X; Chen K; Yan R; Li QS; Zhu HL Bioorg Med Chem; 2012 Jan; 20(2):903-9. PubMed ID: 22192936 [TBL] [Abstract][Full Text] [Related]
15. Regioselective Suzuki coupling of dihaloheteroaromatic compounds as a rapid strategy to synthesize potent rigid combretastatin analogues. Theeramunkong S; Caldarelli A; Massarotti A; Aprile S; Caprioglio D; Zaninetti R; Teruggi A; Pirali T; Grosa G; Tron GC; Genazzani AA J Med Chem; 2011 Jul; 54(14):4977-86. PubMed ID: 21696175 [TBL] [Abstract][Full Text] [Related]
16. Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents. Liou JP; Chang YL; Kuo FM; Chang CW; Tseng HY; Wang CC; Yang YN; Chang JY; Lee SJ; Hsieh HP J Med Chem; 2004 Aug; 47(17):4247-57. PubMed ID: 15293996 [TBL] [Abstract][Full Text] [Related]
17. 2-amino and 2'-aminocombretastatin derivatives as potent antimitotic agents. Chang JY; Yang MF; Chang CY; Chen CM; Kuo CC; Liou JP J Med Chem; 2006 Oct; 49(21):6412-5. PubMed ID: 17034147 [TBL] [Abstract][Full Text] [Related]
18. Naphthalene combretastatin analogues: synthesis, cytotoxicity and antitubulin activity. Medarde M; Maya AB; Pérez-Melero C J Enzyme Inhib Med Chem; 2004 Dec; 19(6):521-40. PubMed ID: 15662956 [TBL] [Abstract][Full Text] [Related]